Light Tower Market Analysis By Lamp (Halides, LEDs), By Power Source (Battery, Diesel, Solar), By End-use Industry (Construction, Mining, Oil & Gas, Commercial & Others) & Region – Global Market Insights 2023 to 2033
The global recombinant protein market is set to enjoy a valuation of US$ 457.1 Million in 2022 and further expand at a CAGR of 4.6% to reach US$ 719.5 Million by the end of 2032.
The market has contributed to 10% of the overall drug market. However, it is anticipated to capture large proportion over the forecast period.
Through genetic engineering, and cell engineering, recombinant protein are produced from creature body. The recombinant protein technology now stands at the edge of biotechnology production. Becoming the new standard, this technology is witnessing a gradual shift from bulk production procedure towards post-production techniques, which in turn promises an enhanced delivery and stability. The highly effective recombinant proteins play an integral part in treating specific diseases, such as haemophilia.
Download Free Sample Copy of This Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=186
Key Takeaways from the Market Study
- Basic research will remain the largest application segment in the global recombinant proteins market. Revenues from basic research will reach roughly US$ 270 Mn in revenues by the end of 2022.
- Toxicity screening, and drug discovery & development will witness the fastest expansion through 2022, based on application of recombinant proteins.
- Recombinant protein sales for forensic testing application will exhibit the lowest CAGR in the market through 2022.
- North America is projected to remain dominant in the global market for recombinant proteins, with sales poised to account for approximately US$ 150 Mn revenues by 2022-end.
- Europe will continue to be the second largest market for recombinant proteins over the forecast period.
- The market for recombinant protein in Middle East & Africa (MEA) will exhibit a sluggish expansion through 2022.
- Academic & research institutes will remain the most lucrative end-users in the global recombinant proteins market, accounting for more than one-third revenue share of the market throughout the forecast period.
- Biopharmaceutical companies will continue to be the fastest expanding end-users of recombinant proteins in the global market.
Share Your Requirements & Get Customized Reports:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=186
Competitive Landscape
Key market players are focusing on products to widen the applications of recombinant proteins in various industries by investing in R&D. Investment to bring novel products into the market is the key strategy among the market leaders. Apart from this, acquisitions, partnerships, and collaborations are some in-organic growth tactics that support maintaining their position in the market.
- In August 2022, Chinese biotechnology company Bao Pharmaceuticals reported that it had raised more than US$ 100 million in a Series B investment round. The company focuses on the commercialization of recombinant protein therapeutics and antibody drugs. The funding was meant to be used for the creation and marketing of medicines made from recombinant proteins. This round was won by Oriental Fortune Capital.
- In March 2020, AMS Biotechnology launched its recombinant protein for the detection of COVID-19 and related RNA viruses. The product launch helped the company to achieve high revenue during the pandemic period.
Key Companies Profiled:
- A.M.S. Biotechnology (Europe) Limited
- Bio-Rad Laboratories Inc.
- BPS Bioscience Inc.
- Abcam plc
- PerkinElmer Inc.
- Crown Bioscience Inc.
- GenScript Corporation
- Merck Millipore Limited
- Sigma Aldrich Company Ltd.
Key Segments :
- By Product Type :
- Immune Checkpoint Regulators
- Chemokines
- Growth Factors
- Cytokines
- Colony Stimulating Factors
- Hormones
- Enzymes & Inhibitors
- Other
- By End User :
- Biopharmaceutical Companies
- Contract Research Organizations (CROs)
- Academic & Research Institutes
- Forensic Science Laboratories
- Food & Beverage Companies
- Diagnostic Centers
- Others
- By Application :
- Drug Discovery & Development
- Basic Research
- Toxicity Screening
- Biopharmaceutical Production
- Drug Screening
- Tissue Engineering
- Forensic Testing
Full Access to this Report Is Available:
https://www.factmr.com/checkout/186
Key Questions Covered in the Recombinant Protein Market Report
- What is the projected value of the Recombinant Protein factors Industry in 2022?
- At what rate will the global Recombinant Protein factors market size grow until 2032?
- Which are the factors hampering the growth of Recombinant Protein factors?
- Which region is expected to lead in the global Recombinant Protein factors market By 2032?
- Which are the factors driving the Recombinant Protein factors Industry during the forecast period?
- What is the expected market value of the Recombinant Protein factors market during the forecast period?
Regional Analysis For Recombinant Protein Market:
- APAC (Japan, China, South Korea, Australia, India, and the rest of APAC; the rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, and Sri Lanka)
- Europe (Germany, UK, France, Spain, Italy, Russia, Rest of Europe; Rest of Europe is further segmented into Belgium, Denmark, Austria, Norway, Sweden, Netherlands, Poland, Czech Republic, Slovakia, Hungary, and Romania)
- North America (USA, Canada and Mexico)
- South America (Brazil, Chile, Argentina, Rest of South America)
- MEA (Saudi Arabia, United Arab Emirates, South Africa)
For More Insights of Fact.MR Trending Report:-
https://www.newswire.co.kr/newsRead.php?no=946690
NB: The information provided in this press release is for general informational purposes only. PRnob publishes this content as submitted and does not independently verify or endorse the information, claims, products, or services mentioned herein.
